I notice Mertons is owned by one of the board members - Mark Licciardo (just an FYI)
I really wonder what this company is setting out to achieve. Are they trying to find partners to get a treatment for Parkinson’s? I don’t know! LCT said they were in talks and close to finalising various agreements “soon”, but we have heard nothing since July’s newsletter. From what I can tell, nothing has happened since the Phase III trials three years ago. My question is, do they want to continue to find a treatment for Parkinson’s? If so, are they actively seeking partners to fund further research? If they are, how are they going? If not, why does this company exist?
Ann: 2020 Annual General Meeting, page-2
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $13.90K | 1.986M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 3764983 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 41489 | 1 |
View Market Depth
| Last trade - 10.57am 15/11/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |